Showing results (701-710 of 853) with videos related to
Sort By:
Pageof 86
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infectionCarolyn A Cohen, Athena Py Li, Asmaa Hachim, et al.Plos One|December 4, 2009
Prevalence of antibodies against avian influenza A (H5N1) virus among Cullers and poultry workers in Ho Chi Minh City, 2005Constance Schultsz, Van Dung Nguyen, Le Thanh Hai, et al.Emerging Infectious Diseases|June 7, 2017
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Pyoeng Gyun Choe, R A P M Perera, Wan Beom Park, et al.Nature Communications|January 5, 2021
Neutralizing antibody titres in SARS-CoV-2 infectionsEric H Y Lau, Owen T Y Tsang, David S C Hui, et al.Veterinary Medicine and Science|September 29, 2023
Ecological characterization of 175 low-pathogenicity avian influenza viruses isolated from wild birds in Mongolia, 2009-2013 and 2016-2018Ariunbaatar Barkhasbaatar, Martin Gilbert, Amanda E Fine, et al.Nature Communications|October 21, 2022
Priming conditions shape breadth of neutralizing antibody responses to sarbecovirusesJanice Zhirong Jia, Chee Wah Tan, Samuel M S Cheng, et al.Emerging Infectious Diseases|March 17, 2016
Nosocomial Co-Transmission of Avian Influenza A(H7N9) and A(H1N1)pdm09 Viruses between 2 Patients with Hematologic DisordersHuazhong Chen, Shelan Liu, Jun Liu, et al.Journal of Virology|July 11, 2014
Expansion of genotypic diversity and establishment of 2009 H1N1 pandemic-origin internal genes in pigs in ChinaHuyi Liang, Tommy Tsan-Yuk Lam, Xiaohui Fan, et al.Journal of Infection and Public Health|May 27, 2022
COVID-19 breakthrough infections in rheumatic diseases patients after vaccinationAbeer N Alshukairi, Awad Al-Omari, Abdurahman Albeity, et al.Biorxiv : the Preprint Server for Biology|November 25, 2020
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2Gang Ye, Joseph P Gallant, Christopher Massey, et al.Pageof 86